Patient discussions are crucial for tailoring IOL choices, ensuring alignment with lifestyle, needs, and surgical outcome ...

The glaucoma treatments developer posted revenue of $105.5 million in the period, which also topped Street forecasts. Nine analysts surveyed by Zacks expected $100.8 million. Glaukos expects full-year ...